Literature DB >> 28985688

Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care: consensus guidance of a Canadian expert panel.

P Durie1, J-D Baillargeon2, S Bouchard3, F Donnellan4, S Zepeda-Gomez5, C Teshima6.   

Abstract

BACKGROUND: Pancreatic exocrine insufficiency (PEI) results in maldigestion due to inadequate activity of pancreatic enzymes in the small bowel. PEI can arise from a variety of medical conditions that reduce enzyme synthesis within the pancreatic parenchyma or from secondary factors that may occur despite optimal parenchymal function, such as pancreatic duct obstruction or impaired or poorly synchronized enzyme release.
PURPOSE: To provide practical guidance for primary care physicians managing patients who are at risk of PEI or who present with symptoms of PEI.
METHODS: For each of six key clinical questions identified by the authors, PubMed searches were conducted to identify key English-language papers up to April 2017. Forward and backward searches on key articles were conducted using Web of Science. Clinical recommendations proposed by the co-chairs (P.D. and C.T.) were vetted and approved based on the authors?
FINDINGS: The most characteristic symptom of PEI is steatorrhea ? voluminous, lipid-rich stools; other common signs and symptoms include unexplained weight loss and deficiencies of fat-soluble vitamins and other micronutrients. Pancreatic enzyme replacement therapy (PERT) can relieve symptoms and long-term sequelae of PEI. Diagnosis of PEI and initiation of PERT are usually the responsibility of gastroenterology specialists. However, primary care physicians (PCPs) are well positioned to identify potential cases of PEI and to participate in the collaborative, long-term management of patients already seen by a specialist.
CONCLUSIONS: In this document, a panel of Canadian gastroenterologists has conducted a critical review of the literature on PEI and PERT and has developed practical diagnostic and treatment recommendations for PCPs. These recommendations provide guidance on identifying patients at risk of PEI, the triggers for PEI testing and referral, and best practices for co-managing patients with confirmed PEI.

Entities:  

Keywords:  Pancreatic enzymes; cystic fibrosis; maldigestion; pancreatitis; steatorrhea; vitamin deficiency

Mesh:

Year:  2017        PMID: 28985688     DOI: 10.1080/03007995.2017.1389704

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  4 in total

1.  Assessment of Exocrine Function of Pancreas Following Pancreaticoduodenectomy.

Authors:  Kiran Thogari; Mallika Tewari; S K Shukla; S P Mishra; H S Shukla
Journal:  Indian J Surg Oncol       Date:  2019-03-18

2.  Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report.

Authors:  Müjde Soytürk; Göksel Bengi; Dilek Oğuz; İsmail Hakkı Kalkan; Mehmet Yalnız; Mustafa Tahtacı; Kadir Demir; Elmas Kasap; Nevin Oruç; Nalan Gülşen Ünal; Orhan Sezgin; Osman Özdoğan; Engin Altıntaş; Serkan Yaraş; Erkan Parlak; Aydın Şeref Köksal; Murat Saruç; Hakan Ünal; Belkıs Ünsal; Süleyman Günay; Deniz Duman; Alper Yurçi; Sabite Kacar; Levent Filik
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.555

Review 3.  Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician.

Authors:  Mohamed O Othman; Diala Harb; Jodie A Barkin
Journal:  Int J Clin Pract       Date:  2018-02-05       Impact factor: 2.503

4.  Assessment of Weight Loss and Gastrointestinal Symptoms Suggestive of Exocrine Pancreatic Dysfunction After Acute Pancreatitis.

Authors:  Anna Evans Phillips; Kohtaro Ooka; Ioannis Pothoulakis; Pedram Paragomi; Nicole Komara; Ali Lahooti; Diala Harb; Melanie Mays; Filippos Koutroumpakis; Kimberly Stello; Phil J Greer; David C Whitcomb; Georgios I Papachristou
Journal:  Clin Transl Gastroenterol       Date:  2020-12-15       Impact factor: 4.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.